In particular, a Wnt5a mimicking peptide, Foxy-5, has been shown to be a promising agent to suppress metastasis of patients with prostate cancer or breast cancer with low endogenous expression of Wnt5a, but it did not affect those with higher endogenous levels of Wnt5a [36, 37]. This evidence concerns the gene WNT5A and prostate cancer.